Intradermal Delivery of Interleukin-12 Plasmid DNA by in vivo Electroporation

Heller, Richard; Schultz, Jan; Lucas, M. Lee; Jaroszeski, Mark J.; Heller, Loree C.; Gilbert, Richard A.; Moelling, Karin; Nicolau, Claude
January 2001
DNA & Cell Biology;Jan2001, Vol. 20 Issue 1, p21
Academic Journal
Gene therapy depends on safe and efficient gene delivery. The skin is an attractive target for gene delivery because of its accessibility. Recently, in vivo electroporation has been shown to enhance expression after injection of plasmid DNA. In this study, we examined the use of electroporation to deliver plasmid DNA to cells of the skin in order to demonstrate that localized delivery can result in increased serum concentrations of a specific protein. Intradermal injection of a plasmid encoding luciferase resulted in low levels of expression. However, when injection was combined with electroporation, expression was significantly increased. When performing this procedure with a plasmid encoding interleukin-12, the induced serum concentrations of gamma-interferon were as much as 10 fold higher when electroporation was used. The results presented here demonstrate that electroporation can be used to augment the efficiency of direct injection of plasmid DNA to skin.


Related Articles

  • 305. Targeting the Gene and the Derived Gene- Product into Tumors*. Shulin Li; Craig, Ryan; Torrero, Marina // Molecular Therapy;Jun2006, Vol. 13, pS117 

    Great effort has been made in developing tumor-targeted gene delivery, but no attention has been given to targeting the therapeutic gene products that are transcribed and translated from genes transfected in normal tissues into tumors. Targeting gene product in tumors is very important for...

  • Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma. Heller, Loree C.; Heller, Richard // Current Gene Therapy;Aug2010, Vol. 10 Issue 4, p312 

    In vivo electroporation (EP) is a versatile delivery method for gene transfer which can be applied to any accessible tissue. Delivery of plasmid DNA encoding therapeutic genes or cDNAs with in vivo EP has been tested extensively in preclinical melanoma models. Direct delivery to the tumor has...

  • CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Jiemiao Hu; Shiguo Zhu; Xueqing Xia; Liangfang Liang; Kleinerman, Eugenie S.; Shulin Li // Molecular Cancer;2014, Vol. 13 Issue 1, p1 

    Background Increased infiltration of CD8+T cells into tumors has a positive impact on survival. Our previous study showed that doxorubicin (Dox) plus interleukin-12 (IL-12) boosted the accumulation of CD8+T cells in tumors and had a greater antitumor effect than did either agent alone. The...

  • Gene delivery tested in mice holds promise for treating melanoma in humans. Newman, Laura // Dermatology Times;Feb2005, Vol. 26 Issue 2, p122 

    The article reports a novel gene therapy approach in mice showing dramatic results in melanoma, but the technique has a long way to go if it is ever to demonstrate its effectiveness in humans. In a report at the 2nd Annual Florida Melanoma Symposium at the University of South Florida,...

  • Cancer Electrogene Therapy with Interleukin-12. Cemazar, Maja; Jarm, Tomaz; Sersa, Gregor // Current Gene Therapy;Aug2010, Vol. 10 Issue 4, p300 

    Electrogene therapy combines administration of plasmid DNA into tissue followed by local application of electric pulses. In electrogene therapy with interleukin-12 (IL-12), different routes of administration, different doses of plasmid DNA and different protocols for delivery of electric pulses...

  • Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2 peptides. Sin, Jeong-Im; Park, Jae-Bok; Lee, In; Park, Daehan; Choi, Youn; Choe, Jongseon; Celis, Esteban // Cancer Immunology, Immunotherapy;Oct2012, Vol. 61 Issue 10, p1671 

    Intratumoral electroporation (IT-EP) with IL-12 cDNA (IT-EP/IL12) can lead to the eradication of established B16 melanoma tumors in mice. Here, we explore the immunological mechanism of the antitumor effects generated by this therapy. The results show that IT-EP/IL12 applied only once resulted...

  • Electrogene therapy with interleukin-12 in canine mast cell tumors. Pavlin, Darja; Cemazar, Maja; Cör, Andrej; Sersa, Gregor; Pogacnik, Azra; Tozon, Natasa // Radiology & Oncology;2011, Vol. 45 Issue 1, p30 

    Background. Mast cell tumors (MCT) are the most common malignant cutaneous tumors in dogs with extremely variable biological behaviour. Different treatment approaches can be used in canine cutaneous MCT, with surgical excision being the treatment of choice. In this study, electrogene therapy...

  • Inhibition of Established Subcutaneous and Metastatic Murine Tumors by Intramuscular Electroporation of the Interleukin-12 Gene. Shan-Chih Lee, George C.; Chang-Jer Wu, George C.; Pin-Yi Wu, George C.; Yi-Ling Huang, George C.; Cheng-Wen Wu; Mi-Hua Tao // Journal of Biomedical Science;Jan/Feb2003, Vol. 10 Issue 1, p73 

    In vivo electroporation (EP) of the murine interleukin-12 (IL-12) gene in an expression plasmid (pIL-12) was evaluated for antitumor activity. EP transfer of pIL-12 into mouse quadriceps muscles elicited significant levels of serum IL-12 and interferon-γ. Intramuscular EP of pIL-12 resulted...

  • Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy. Reed, S D; Li, S // Cancer Gene Therapy;Apr2011, Vol. 18 Issue 4, p265 

    This study's goal was to assess the safety of tumor-targeted interleukin-12 (ttIL-12) when administered by electrogenetherapy in C3H/HeJ mice by identifying an initial safe dose for human dose escalation schemes, toxicity target organs, markers of toxicity, and toxicity reversibility. Tumor-free...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics